Syntonix raises $35.8 million

Syntonix Pharmaceuticals raised $35.8 million in a series B financing led by Bay City Capital and Alta Partners. Other investors included A.M. Pappas; Global Biomedical Partners; AFB Fund; Venrock Ass...